Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Allergan recalls pregnancy prevention pills due to out of sequence capsules
May 30, 2018 Off

Allergan recalls pregnancy prevention pills due to out of sequence capsules

By Dino Mustafić

Allergan is recalling one lot of Taytulla physicians sample pack, indicated for use by women to prevent pregnancy, because of…

AstraZeneca’s COPD drug failed to meet the primary endpoint
May 30, 2018 Off

AstraZeneca’s COPD drug failed to meet the primary endpoint

By Dino Mustafić

AstraZeneca and MedImmune, said that the trial Terranova, the second of two pivotal Phase III trials for Fasenra (benralizumab) in patients…

Akers withdraw its application for PIFA CHlamydia AKR.L
May 29, 2018 Off

Akers withdraw its application for PIFA CHlamydia AKR.L

By Dino Mustafić

Akers Biosciences has decided to withdaw its initial 510(k) application for PIFA Chlamydia in order to re-evaluate its options with…

FDA accepts larotrectinib Bayer’s New Drug Application and grants priority review
May 29, 2018 Off

FDA accepts larotrectinib Bayer’s New Drug Application and grants priority review

By Dino Mustafić

The U.S. Food and Drug Administration (FDA) has accepted Bayer’s partner’s Loxo Oncology’s New Drug Application (NDA), and granted Priority…

Novartis reports significant improvement in symptom frequency and quality of life domains with Entresto
May 29, 2018 Off

Novartis reports significant improvement in symptom frequency and quality of life domains with Entresto

By Dino Mustafić

Novartis has gotten new evidence from the CHAMP-HF registry comparing Entresto patients to patients not taking Entresto, which showed that…

FDA warns about certain OTC teething products being risky for children
May 28, 2018 Off

FDA warns about certain OTC teething products being risky for children

By Dino Mustafić

The U.S. Food and Drug Administration has issued a warning about the over-the-counter (OTC) teething products containing benzocaine pose a…

AstraZeneca’s Imfinzi improves overall survival in trial for cell lung cancer
May 25, 2018 Off

AstraZeneca’s Imfinzi improves overall survival in trial for cell lung cancer

By Dino Mustafić

AstraZeneca and MedImmune, its global biologics research and development arm, on Friday reported positive overall survival (OS) results for the…

FDA OK’s AkaRx’s liver drug
May 25, 2018 Off

FDA OK’s AkaRx’s liver drug

By Dino Mustafić

The U.S. Food and Drug Administration has approved AkaRx’s Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with…

May 24, 2018 Off

Lilly to seek replacement for oncology president

By Dino Mustafić

Eli Lilly said Thursday its senior vice president and president of Lilly Oncology, and the member of the company’s executive…

Novartis’s Zessly approved in Europe
May 24, 2018 Off

Novartis’s Zessly approved in Europe

By Dino Mustafić

Novartis’s Sandoz has secured European Commission’s approval for biosimilar Zessly, the company said Thursday.

Posts pagination

Previous 1 … 3,389 3,390 3,391 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine